Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 211,152,084 papers from all fields of science
Search
Sign In
Create Free Account
Hepatitis, Chronic
Known as:
Chronic hepatitis, unspecified
, CHRONIC HEPATITIS
, Hepatitis, Chronic [Disease/Finding]
Expand
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Narrower (4)
Chronic Persistent Hepatitis
Chronic active hepatitis
Cryptogenic Chronic Hepatitis
Hepatitis B, Chronic
Broader (1)
Chronic inflammation
Gastrointestinal system
Glycogen Storage Disease XIV
Hepatitis
Hepatitis, Autoimmune
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Telaprevir for previously untreated chronic hepatitis C virus infection.
I. Jacobson
,
J. McHutchison
,
+20 authors
S. Zeuzem
New England Journal of Medicine
2011
Corpus ID: 23771082
BACKGROUND In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with…
Expand
Review
2010
Review
2010
Chronic hepatitis B : an update
N. Tsai
,
N. Gitlin
2010
Corpus ID: 69065519
A recent Institute of Medicine report has concluded that 'there is a lack of knowledge and awareness about chronic viral…
Expand
Highly Cited
2009
Highly Cited
2009
Chronic hepatitis B: Update 2009
A. Lok
,
B. McMahon
Hepatology
2009
Corpus ID: 205871381
The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic…
Expand
Highly Cited
2003
Highly Cited
2003
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
C. Wai
,
J. Greenson
,
+4 authors
A. Lok
Hepatology
2003
Corpus ID: 2919658
Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for…
Expand
Highly Cited
2002
Highly Cited
2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
M. Fried
,
M. Shiffman
,
+11 authors
J. Yu
New England Journal of Medicine
2002
Corpus ID: 22638227
BACKGROUND Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment…
Expand
Highly Cited
1998
Highly Cited
1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
J. McHutchison
,
S. Gordon
,
+7 authors
J. Albrecht
New England Journal of Medicine
1998
Corpus ID: 11861009
BACKGROUND Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virologic response to interferon therapy…
Expand
Review
1996
Review
1996
An algorithm for the grading of activity in chronic hepatitis C
P. Bedossa
,
T. Poynard
Hepatology
1996
Corpus ID: 44385981
Histological activity reflects the global assessment of basic necroinflammatory lesions and is a criterion of major importance in…
Expand
Review
1995
Review
1995
Histological grading and staging of chronic hepatitis.
K. Ishak
,
A. Baptista
,
+7 authors
R. N. Macsween
Journal of Hepatology
1995
Corpus ID: 10314247
Review
1994
Review
1994
Classification of chronic hepatitis: Diagnosis, grading and staging
V. Desmet
,
M. Gerber
,
J. Hoofnagle
,
M. Manns
,
P. Scheuer
Hepatology
1994
Corpus ID: 2658045
Di Bisceglie A et al. Long-erm clinical and histopathological follow-up of chronic posttransfusion hepatitis 14: 969-974 405…
Expand
Highly Cited
1981
Highly Cited
1981
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
R. Knodell
,
K. Ishak
,
+5 authors
J. Wollman
Hepatology
1981
Corpus ID: 6558246
A Histology Activity Index has been developed which generates a numerical score for liver biopsy specimens obtained from patients…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE